OKYO Pharma Limited (NASDAQ: OKYO) announced it received positive feedback from a U.S. Food and Drug Administration Type D meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE